Page 30 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delhi HC adjourns hearing on PIL seeking reduction in price of Covid-19 vaccine

Delhi HC adjourns hearing on PIL seeking reduction in price of Covid-19 vaccine ANI | Updated: May 17, 2021 14:23 IST New Delhi [India], May 17 (ANI): The Delhi High Court on Monday adjourned the hearing on a Public Interest Litigation (PIL) that sought direction to the respondents to reduce the price of anti-coronavirus vaccine for citizens of the country. The bench of Justice DN Patel and Justice Jyoti Singh deferred the matter after taking note that the Supreme Court of India is already examining a similar matter. The petitioner Rakesh, social activist, through Advocates AK Dubey and Pawan Kumar stated that earlier the price of vaccine at a private hospital was Rs 250, which was reasonable. It is not easy for most people to pay the increased cost of anti-Corona vaccine as it raises the expenses of the common people.

New delhiWest bengalTamil naduPawan kumarJustice jyoti singhSupreme courtUnion of indiaDelhi high court onSerum institute of indiaMinistry of external affairsDelhi high courtPublic interest litigationHyderabad based bharat biotechPune based serum instituteSri lankaExternal affairs

Disneyland Paris will reopen June 17

Disneyland Paris will reopen June 17 From CNN s Barbara WojazerÂ Chesnot/Getty Images People arrive at Disneyland Paris on July 13, 2020, in Marne-la-Vallee, France. Disneyland Paris will reopen its doors to visitors on June 17, Disney Parks said in a statement Monday. The park has been closed since October when France went into a second nationwide lockdown to curb rising coronavirus infections. Other Disney venues are also reopening according to the statement, including Walt Disney Studios Park, Disneyâs Newport Bay Club and Disney Village. Disneyâs Hotel New York â The Art of Marvel will also open on June 21, with sales opening on May 18.

New yorkUnited statesUnited kingdomFrance generalNew delhiUttar pradeshSri lankaMarne la valleeÎe de franceKrung thep mahanakhonGlaxosmithkline covidAmanda daviesBrad adamsSanofi pasteurCharly triballeauThomas triomphe

UP govt expands global vaccine tender, makes way for Moderna, Pfizer, Cadila to place bids

UP govt expands global vaccine tender, makes way for Moderna, Pfizer, Cadila to place bids
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshOxford astrazeneca covishieldSerum institute of indiaHyderabad based bharat biotechPune based serum instituteஉத்தர் பிரதேஷ்சீரம் நிறுவனம் ஆஃப் இந்தியாஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்புனே அடிப்படையிலானது சீரம் நிறுவனம்

COVID-19: Telangana daily cases decline; shortage halts 2nd dose of Covaxin

COVID-19: Telangana daily cases decline; shortage halts 2nd dose of Covaxin The cumulative count of COVID-19 cases in Telangana has crossed 5.28 lakh on Sunday. By Sakina Fatima| Updated: 17th May 2021 1:29 am IST Representative Image Photo: PTI Hyderabad: The second dose of Covaxin (developed by Hyderabad-based Bharat Biotech) vaccination drive for the persons above 45-years old was postponed due to inadequate stock and non-receipt of fresh stocks from the ministry of health and family welfare. The update was posted in a tweet by Telangana State Public Health Department director Dr G Srinivasa Rao on Sunday here. Dr. Srinivasa Rao further said that details regarding resumption of vaccination drive will be made subsequently. If government statistics, the second wave of the COVID-19 crisis in Telangana is easing gradually with the state recording 3,816 fresh COVID-19 cases in the last 24 hours, according to Sunday’s data. This was the lowest since April 15, when the stat

Andhra pradeshSrinivasa raoG srinivasa raoTelangana state public health departmentGreater hyderabad municipal corporationHyderabad based bharat biotechCorona virusCovid 19Ovid 19 casesCovid 19 deathsOvid 19 pandemicOvid 19 positiveCovid 19 vaccineHyderabad covidHyderabad covid 19 updateHyderabad news

Chidambaram slams Centre for delay in decision taking regarding inviting other Covaxin manufacturers | India News

NEW DELHI: Pointing out the Centre s delay in taking decision, former finance minister and senior Congress leader P Chidambaram on Saturday asked who will be accountable for the avoidable infections and loss of lives due to the central government s delay to invite other vaccine manufacturers to produce Covaxin. In a series of tweets, Chidambaram said the suggestion for compulsory licences be issued to other manufacturers had been offered by the Congress four weeks before the government took the decision. Four weeks after the CWC demanded that compulsory licenses be issued to other manufacturers, the central government has decided to invite other manufacturers to apply to produce Covaxin ! he said.

Abhishek singhviP chidambaram pchidambaramHyderabad based bharat biotechNdia newsNdia news todayOday newsGoogle newsReaking newsUnion health ministryBharat biotechஅபிஷேக் சிங்விஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்தொழிற்சங்கம் ஆரோக்கியம் அமைச்சகம்பாரத் பயோடெக்